Pfizer TLZ 0.25 Pill - white capsule/oblong, 14mm

Generic Name: talazoparib

Pill with imprint Pfizer TLZ 0.25 is White, Capsule/Oblong and has been identified as Talzenna 0.25 mg. It is supplied by Pfizer Inc.

Talzenna is used in the treatment of Breast Cancer; Prostate Cancer and belongs to the drug class PARP inhibitors. Talzenna 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer TLZ 0.25

Talzenna

Generic Name

talazoparib

Imprint

Pfizer TLZ 0.25

Strength

0.25 mg

Color

White

Size

14.00 mm

Shape

Capsule/Oblong

Availability

Prescription only

Drug Class

PARP inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Pfizer Inc.

National Drug Code (NDC)

00069-0296

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer